1,110 results on '"Takehara, Kazuhiko"'
Search Results
202. Oropharyngeal Dysphagia in Dermatomyositis: Associations with Clinical and Laboratory Features Including Autoantibodies
203. Clinical Utility of an Enzyme-Linked Immunosorbent Assay for Detecting Anti-Melanoma Differentiation-Associated Gene 5 Autoantibodies
204. Human Leukocyte Antigen and Systemic Sclerosis in Japanese: The Sign of the Four Independent Protective Alleles, DRB1*13:02, DRB1*14:06, DQB1*03:01, and DPB1*02:01
205. A case of psoriasis vulgaris with multiple squamous cell carcinomas that presented with right inguinal lymph node metastasis
206. A case of Merkel cell carcinoma of the right big toe with Merkel cell polyomavirus infection
207. A case of myxofibrosarcoma with lung metastasis
208. Decreased levels of regulatory B cells in patients with systemic sclerosis: association with autoantibody production and disease activity
209. Identification of ribonucleotide reductase mutation causing temperature‐sensitivity of herpes simplex virus isolates from whitlow by deep sequencing
210. Identification of Myocardial Damage in Systemic Sclerosis: A Nuclear Cardiology Approach
211. Proteomic identification of heterogeneous nuclear ribonucleoprotein K as a novel cold-associated autoantigen in patients with secondary Raynaud’s phenomenon
212. Blockade of Syk ameliorates the development of murine sclerodermatous chronic graft-versus-host disease
213. Autoantibodies to RuvBL1 and RuvBL2: A Novel Systemic Sclerosis-Related Antibody Associated With Diffuse Cutaneous and Skeletal Muscle Involvement
214. The clinical characteristics of juvenile-onset systemic sclerosis in Japanese patients
215. Serum Adhesion Molecule Levels as Prognostic Markers in Patients with Early Systemic Sclerosis: A Multicentre, Prospective, Observational Study
216. Cutaneous necrotizing vasculitis in a patient with dermatomyositis positive for anti-PL-7 antibody
217. High incidence of pulmonary arterial hypertension in systemic sclerosis patients with anti-centriole autoantibodies
218. Alu-mediated large deletion of the CDSN gene as a cause of peeling skin disease
219. Cutaneous Mycobacterium chelonae infection in a rheumatoid arthritis patient treated with etanercept
220. Prurigo nodularis-like skin eruptions in a patient with IgG4-related disease
221. FTY720 ameliorates murine Scl-cGVHD by promoting expansion of splenic regulatory cells and inhibiting immune cell infiltration into the skin (P5153)
222. The clinical characteristics of juvenile-onset systemic sclerosis in Japanese patients
223. Common and Distinct Clinical Features in Adult Patients with Anti-Aminoacyl-tRNA Synthetase Antibodies: Heterogeneity within the Syndrome
224. Dermokine inhibits ELR+CXC chemokine expression and delays early skin wound healing
225. Chemokine receptors CCR2 and CX3CR1 regulate skin fibrosis in the mouse model of cytokine-induced systemic sclerosis
226. FTY720 ameliorates sclerodermatous chronic GVHD by expansion of splenic regulatory cells and inhibition of skin immune cell infiltration
227. Altered expression of dermokine in skin disorders
228. BLNK expression is essential for IL-10 production in regulatory B cells that inhibit contact hypersensitivity
229. PI3K-Akt pathway modulates IL-10 producing regulatory B cell
230. Circulating γ/δ T cells in systemic sclerosis exhibit activated phenotype and enhance gene expression of proalpha2(I) collagen of fibroblasts
231. Anti‐topoisomerase I antibody levels as serum markers of skin sclerosis in systemic sclerosis
232. Potential Immunologic Targets for Treating Fibrosis in Systemic Sclerosis: A Review Focused on Leukocytes and Cytokines
233. IL-6 Blockade Attenuates the Development of Murine Sclerodermatous Chronic Graft-Versus-Host Disease
234. Serum chemokine levels as prognostic markers in patients with early systemic sclerosis: a multicenter, prospective, observational study
235. Clinical and laboratory features dependent on age at onset in Japanese systemic sclerosis
236. Basophils and mast cells play critical roles for leukocyte recruitment in IgE-mediated cutaneous reverse passive Arthus reaction
237. Autoantibodies to small ubiquitin-like modifier activating enzymes in Japanese patients with dermatomyositis: comparison with a UK Caucasian cohort
238. Association ofUBE2L3polymorphisms with diffuse cutaneous systemic sclerosis in a Japanese population: Table 1
239. RXRBIs an MHC-Encoded Susceptibility Gene Associated with Anti-Topoisomerase I Antibody-Positive Systemic Sclerosis
240. Egr-1 Induces a Profibrotic Injury/Repair Gene Program Associated with Systemic Sclerosis
241. Use of Serum Clara Cell 16-kDa (CC16) Levels as a Potential Indicator of Active Pulmonary Fibrosis in Systemic Sclerosis
242. IgG4-Related Skin Disease, a Mimic of Angiolymphoid Hyperplasia with Eosinophilia
243. A Phase III, Multicenter, Collaborative, Open-Label Clinical Trial of Sildenafil in Japanese Patients With Pulmonary Arterial Hypertension
244. IgG4-related Skin Lesions in a Patient with IgG4-related Chronic Sclerosing Dacryoadenitis and Sialoadenitis
245. An examination of the risk factors associated with metastasis and local recurrence of cutaneous squamous cell carcinoma for patients with spinalioma
246. Serum chemokine and cytokine levels as indicators of disease activity in patients with systemic sclerosis
247. Elevated serum placenta growth factor (PlGF) levels in patients with systemic sclerosis: A possible role in the development of skin but not lung fibrosis
248. N-terminal Connective Tissue Growth Factor (CTGF) Is A Potential Biomarker Of Idiopathic Interstitial Pneumonias (IIPs)
249. Subtraction method for determination of N-terminal connective tissue growth factor
250. Inducible costimulator ligand regulates bleomycin-induced lung and skin fibrosis in a mouse model independently of the inducible costimulator/inducible costimulator ligand pathway
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.